Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001209191-23-054907

10% owner bought 227,272 shares at $11.00 ($2,499,992)

  • 10% owner acquired 1,608,687 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Lundbeckfond Invest A/S 10% owner 2023-11-07 Conversion +1,321,474 1,321,474 D
Lundbeckfond Invest A/S 10% owner 2023-11-07 Conversion +287,213 1,608,687 D
Lundbeckfond Invest A/S 10% owner 2023-11-07 Purchase +227,272 $11.00 $2,499,992 1,835,959 D
Derivatives
Lundbeckfond Invest A/S 10% owner 2023-11-07 Conversion · Series A convertible preferred stock −13,999,999 0 D
Lundbeckfond Invest A/S 10% owner 2023-11-07 Conversion · Series B convertible preferred stock −2,615,533 0 D
Open-market purchases · 227,272 sh · avg $11.00 · $2,499,992
Loading xslF345X05/doc4.xml…